معرفی
Professor Ten Feizi is a distinguished academic and Director of the Glycosciences Laboratory at Imperial College London's Faculty of Medicine. She holds dual MB BS (1961) and MD (1969) degrees from the Royal Free Hospital Medical School. Her research focuses on glycobiology, carbohydrate recognition systems, and their roles in immune responses, infectious diseases, and cancer. Key contributions include pioneering the neoglycolipid (NGL) technology and glycoarray systems, which revolutionized glycan-based research. Her work on HIV gp120 glycans and selectin ligands has advanced vaccine development and molecular medicine.
- Education: MB BS (1961), MD (1969), Royal Free Hospital Medical School
- Affiliations: Glycosciences Laboratory, Membrane Receptor Network
Her research interests span glycobiology, immunology, and microbiology, with a focus on glycan roles in disease mechanisms and host-pathogen interactions. Notable achievements include defining F77 (prostate cancer antigen) and R10G (pluripotent stem cell marker) structures, and elucidating viral attachment mechanisms via glycan arrays.
Professor Feizi has received prestigious awards, including Royal Society Fellowship and the Rosalind Kornfeld Lifetime Achievement Award. Her lab develops cutting-edge glycan array tools (e.g., CarbArrayART) to study glycome interactions in health/disease contexts.
Current work involves glycan-viral interactions (e.g., influenza, adenoviruses), vaginal microbiome-glycan links in preterm birth, and glycan-based therapies for fungal infections. She collaborates internationally to advance glycobiology standards (MIRAGE project) and translational glycomics.
